Trans-Ver-Sal PediaPatch Drug Information [ Bristol-Myers Squibb; Bradley Pharmaceuticals ]

Table of content

Trans-Ver-Sal PediaPatch category:

• Human
• Acne Therapy
• Antidandruff Products
• Antiseptic Skin Cleansers
• Keratolytic Agents
• Other Miscellaneous Antibacterial Agents

Active ingredients:

• Salicylic Acid

Trans-Ver-Sal PediaPatch companies and manufacturers:

• Bristol-Myers Squibb

• Bradley Pharmaceuticals

General Information

Trans-Ver-Sal PediaPatch forms, composition and dosages:

• Patch; Topical; Salicylic Acid

Indications, usages and classification codes:

• D02AF - Salicylic Acid preparations

There is an additional general information about this medication active ingredient salicylic acid:

Pharmacological action

Salicylic acid is pharmaceytical active ingredient for topical use. Inhibits the secretion of the sebaceous and sweat glands. At low concentrations it has keratoplastic and in high doses keratolytic effect. Salicylic acid has a weak antimicrobial activity.

Why is Trans-Ver-Sal PediaPatch prescribed?

Monotherapy and as part of combination therapies for inflammatory, infectious and other skin lesions, including burns, psoriasis, eczema, dyskeratosis, ichthyosis, acne vulgaris, warts, hyperkeratosis, corn, callus, oily seborrhea, scaly skin disease, hair loss, sweating feet.

Dosage and administration

It is applied to the skin surface 2-3 times / day.

Trans-Ver-Sal PediaPatch side effects

Rarely: local reactions such as itching, burning, skin rashes, allergic reactions.

Contraindications

Hypersensitivity to salicylic acid, renal failure, infancy.

Special instructions

The composition of the solution for topical use include ethanol.

Trans-Ver-Sal PediaPatch drug interactions

Pharmaceutically not compatible with resorcinol (forms melted mixture) and zinc oxide (forms insoluble forms of zinc salicylate).

• Trans-Ver-Sal PediaPatch analogs
• Trans-Ver-Sal PediaPatch similar